Frederick National Laboratory for Cancer Research
8560 Progress Drive,
Frederick, 21701, MD,
United States
Frederick, 21701, MD,
United States
1 301-846-1000
Healthcare
Frederick National Laboratory for Cancer Research Technographics
Frederick National Laboratory for Cancer Research Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Frederick National Laboratory for Cancer Research and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2400 Frederick National Laboratory for Cancer Research employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Frederick National Laboratory for Cancer Research has purchased the following applications: Corcentric Accounts Payable Automation for AP Automation in 2019, Gallup Q12 for Employee Engagement in 2023, Certara D360 for Laboratory Management in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Frederick National Laboratory for Cancer Research is running and its propensity to invest more and deepen its relationship with Corcentric , Gallup , Certara or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Frederick National Laboratory for Cancer Research revenues, which have grown to $600.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Frederick National Laboratory for Cancer Research intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Frederick National Laboratory for Cancer Research Tech Stack and Enterprise Applications
ERP Financial Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Corcentric | Legacy | Corcentric Accounts Payable Automation | AP Automation | ERP Financial Management | n/a | 2019 | 2019 |
In 2019 Frederick National Laboratory for Cancer Research implemented Corcentric Accounts Payable Automation to centralize invoice processing for finance and accounts payable teams, using the solution as their AP Automation platform. The deployment centered on digitizing invoice intake and standardizing approval workflows across the laboratory finance function, with the Corcentric Accounts Payable Automation instance positioned as the system of record for vendor invoices and transaction coding.
Configuration emphasized invoice capture, automated validation and exception handling, workflow routing for multilevel approvals, and invoice validation against purchasing documents where applicable. The implementation leveraged Corcentric Invoice Payables experience to configure role-based approval flows, centralized document storage, and audit trail capabilities consistent with institutional compliance and financial controls.
The environment was integrated with Deltek Costpoint for financial posting and ledger synchronization and with IBM Cognos for transaction-level reporting and analytics, enabling AP transaction data to flow into Costpoint for GL updates and into Cognos for consolidated reporting. Data integrations focused on synchronizing vendor master data, invoice header and line details, and payment status between Corcentric Accounts Payable Automation and the laboratory financial and reporting systems.
Governance changes included formalized invoice routing rules, centralized invoice exception management processes, and updated AP operational procedures to align teams on a single automated workflow. The rollout was structured around finance and accounts payable operational coverage, embedding the Corcentric Accounts Payable Automation solution into existing accounting and reporting operations at Frederick National Laboratory for Cancer Research.
|
HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Gallup | Legacy | Gallup Q12 | Employee Engagement | HCM | n/a | 2023 | 2023 |
In 2023, Frederick National Laboratory for Cancer Research implemented Gallup Q12 as an enterprise Employee Engagement assessment. The federally funded NCI/NIH contract organization in Frederick, Maryland deployed Gallup Q12 under the Senior Vice President of Human Resources, who served from January 2023 through June 2023, to establish a baseline engagement profile for roughly 2,400 employees.
The Gallup Q12 deployment centered on core assessment workflows, including standardized survey administration, aggregation of engagement scores, and manager level scorecards to surface team strengths and development areas. Configuration emphasized recurring pulse surveys and role based reporting, with the Gallup Q12 application providing the assessment instrument, scorecarding, and engagement dimension tracking used by HR and people managers.
Operational coverage focused on Human Resources, people managers, and senior leadership at the Frederick site, with Gallup Q12 applied enterprise wide to inform workforce planning and employee relations. The implementation positioned Gallup Q12 as the primary Employee Engagement measurement within HR processes and reporting.
Governance was adjusted to fold Gallup Q12 results into HR reporting cadence and planning cycles, supporting a benefits planning process launched for 2024 that included a stated target to reduce costs by 10 percent. The implementation established a repeatable engagement measurement practice intended to inform manager coaching, workforce decisions, and benefits planning.
|
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Certara | Legacy | Certara D360 | Laboratory Management | ERP Services and Operations | n/a | 2022 | 2022 |
In 2022, Frederick National Laboratory for Cancer Research deployed Certara D360 as a Laboratory Management application to centralize drug discovery data and program oversight for the NCI Experimental Therapeutics NExT Program Chemical Biology Consortium. The deployment was focused on supporting medicinal chemistry and project management workflows at the Frederick site, enabling coordination from hit to lead through preclinical development across CBC project teams and scientific stakeholders.
Certara D360 was configured to serve data management and analysis functions, combining experimental data capture with project tracking and high level reporting capabilities. Configuration emphasized support for structure based inhibitor design workflows, with users leveraging the platform to organize compound data, track synthetic routes and annotate project milestones, while project managers used the system for timeline and budget visibility.
The implementation was used alongside and integrated with existing scientific tools that are explicitly referenced in operational notes, including DataWarrior for cheminformatics, CambridgeSoft eLN for electronic lab notebook workflows, ADMET Predictor and MetaSite for metabolism and ADMET modeling, and in silico modeling outputs from Maestro Glide and MOE. This integration pattern positioned Certara D360 as a central laboratory management hub that federates assay results, modeling outputs and ELN records for cross functional teams in medicinal chemistry and chemical biology.
Governance and process adoption focused on cross functional collaboration and program reporting, with Certara D360 workflows used to facilitate project initiation, team orientation, subcontractor reviews and preparation of high level quarterly reports for NCI management. Day to day operational governance tied system usage to project management responsibilities, enabling scientific project managers to act as liaisons between NCI leadership, CBC centers and external collaborators while maintaining structured data and audit trails within the Laboratory Management environment.
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Automation | CRM |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Frederick National Laboratory for Cancer Research
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Frederick National Laboratory for Cancer Research Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Frederick National Laboratory for Cancer Research IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Frederick National Laboratory for Cancer Research digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Frederick National Laboratory for Cancer Research Technographics
Frederick National Laboratory for Cancer Research is a Healthcare organization based in United States,
with around 2400 employees and annual revenues of $600.0 million.
Frederick National Laboratory for Cancer Research operates a diverse technology stack with applications such as
Corcentric Accounts Payable Automation, Gallup Q12 and Certara D360,
covering areas like AP Automation, Employee Engagement and Laboratory Management.
Frederick National Laboratory for Cancer Research has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Corcentric, Gallup and Certara.
Frederick National Laboratory for Cancer Research recently adopted applications including
Gallup Q12 in 2023, Certara D360 in 2022 and Acquia Campaign Studio (ex Mautic) in 2020,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Frederick National Laboratory for Cancer Research’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Frederick National Laboratory for Cancer Research’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Frederick National Laboratory for Cancer Research technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.